Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · IEX Real-Time Price · USD
1.800
-0.160 (-8.16%)
At close: Apr 24, 2024, 2:33 PM
1.860
+0.060 (3.33%)
After-hours: Apr 24, 2024, 6:22 PM EDT
Company Description
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies.
Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system.
The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Eterna Therapeutics Inc.
| Country | United States |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Sanjeev Luther |
Contact Details
Address: 1035 Cambridge Street, Suite 18a Cambridge, Massachusetts 02141 United States | |
| Phone | (212) 582-1199 |
| Website | brooklynitx.com |
Stock Details
| Ticker Symbol | ERNA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000748592 |
| ISIN Number | US1140822099 |
| Employer ID | 31-1103425 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sandra M. Gurrola | Principal Financial and Accounting Officer and Senior Vice President of Finance |
| Sanjeev Luther | Chief Executive Officer, President and Director |
| Dorothy J. Clarke | General Counsel and Director |
| Megan Yung | Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 22, 2024 | 8-K | Current Report |
| Mar 18, 2024 | 10-K/A | [Amend] Annual report |
| Mar 14, 2024 | 10-K | Annual Report |
| Feb 16, 2024 | 8-K | Current Report |
| Jan 31, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 24, 2024 | 424B3 | Prospectus |
| Jan 22, 2024 | EFFECT | Notice of Effectiveness |
| Jan 19, 2024 | 8-K | Current Report |
| Jan 19, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 17, 2024 | UPLOAD | Filing |